Home » Topics » Regulatory » Patents

Patents
RSS

University of Texas System patents mitochondrial GLS1 inhibitors

Jan. 27, 2016

Novartis reports soluble guanylate cyclase activators

Jan. 26, 2016

Sunshine Lake Pharma discloses JAK3 inhibitors

Jan. 26, 2016

Polish institutions report 5-HT/dopamine receptor modulators

Jan. 26, 2016

Pharmacyclics reports BTK inhibitors

Jan. 25, 2016

ST Pharm presents tankyrase-1 inhibitors

Jan. 25, 2016

Incyte discloses KDM1A inhibitors

Jan. 25, 2016

Genentech and Xenon Pharmaceuticals patent Nav1.7 channel blockers

Jan. 25, 2016

Ajinomoto divulges GS activators

Jan. 22, 2016

Hetero Research Foundation presents antiviral agents

Jan. 22, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...